EIA report of Tianli Pharmaceutical's VC deep processing project (Phase two) approved
Summary: At the end of January, the EIA report of Tianli Pharmaceutical's VC deep processing project (Phase two: 2,500 t/a calcium ascorbate, 10,000 t/a L-Ascorbate-2-Phosphate) was approved by the Ecology and Environment Bureau of Shouguang City.In ...
Vitamins China E-News 202002